Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc for GVHD Prophylaxis in HLA-Mismatched HSCT
NCT02799888Phase 2Unknown
- Sponsor
- Academy of Military Medical Sciences
- Start
- Apr 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of maraviroc in graft-versus-host disease (GVHD), sponsored by Academy of Military Medical Sciences. Status: unknown.
02
Drugs
maraviroc
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT02799888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02799888.